Clinical Trials Browser

Phase 3 × Leukemia, B-Cell × Clear all

Hematologic Diseases, Leukemia, Lymphoid, Lymphoma, Non-Hodgkin, Leukemia, B-Cell, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-Cell

NCT04608318 2024-12-31

CLL17

Phase 3 Active not recruiting

897 enrolled

LymphoidOther hematologic neoplasm

Leukemia, B-Cell

NCT03836261 2024-12-27

AMPLIFY

Phase 3 Active not recruiting

984 enrolled 1 FDA

LymphoidOther hematologic neoplasm

Leukemia, Leukemia, B-Cell, Leukemia, Lymphocytic, Chronic, B-Cell

NCT01518959 2020-07-16

D-HEM

Phase 3 Terminated

31 enrolled

LymphoidOther hematologic neoplasm

Leukemia, B-Cell

NCT00824265 2020-06-18

Ofatumumab Added to Fludarabine-Cyclophosphamide vs Fludarabine-Cyclophosphamide Combination in Relapsed Subjects With Chronic Lymphocytic Leukemia

Phase 3 Completed

365 enrolled 28 charts

LymphoidOther hematologic neoplasm

Neoplasms, Recurrence, Leukemia, B-Cell, Leukemia, Lymphocytic, Chronic, B-Cell

NCT01039376 2019-07-30

PROLONG

Phase 3 Terminated

480 enrolled 30 charts

LymphoidOther hematologic neoplasm

Leukemia, B-Cell

NCT00748189 2019-06-25

COMPLEMENT 1

Phase 3 Terminated

447 enrolled 32 charts

LymphoidOther hematologic neoplasm

Neoplasms, Leukemia, B-Cell, Leukemia, Lymphocytic, Chronic, B-Cell

NCT01678430 2012-10-15

RIAltO

Phase 3 Unknown

670 enrolled

LymphoidOther hematologic neoplasm

Leukemia, B-Cell

Clinical Trials

BRUIN-CLL-314

CLL17

AMPLIFY

D-HEM

Ofatumumab Added to Fludarabine-Cyclophosphamide vs Fludarabine-Cyclophosphamide Combination in Relapsed Subjects With Chronic Lymphocytic Leukemia

PROLONG

COMPLEMENT 1

RIAltO